Vaccine against epidemic gastroenteritis being tested
(Medical Xpress) -- A new vaccine is being tested in the US that may protect against the norovirus, which causes "stomach flu" or acute viral gastroenteritis, that can occur in confined living settings such as cruise ships, nursing homes, hospitals, schools, and military establishments.
Norovirus illness symptoms include acute onset diarrhea, nausea, vomiting, and abdominal cramps, and the disease can range from being a mere nuisance to extremely severe or fatal, especially in immune-compromised individuals and in people in developing countries. In the US alone norovirus illnesses are responsible for over one million hospitalizations each year.
The team of researchers, led by Dr Robert Atmar of the Baylor College of Medicine in Houston, Texas, have demonstrated for the first time that a vaccine can be effective in preventing illnesses caused by the norovirus. Only one vaccine for gastrointestinal disease currently exists, and this protects against the rotavirus, which causes severe diarrhea in babies and young children.
The norovirus vaccine is not expected to be available for at least five years, and possibly as long as a decade. The vaccine currently being tested contains viruslike particle (VLP) antigens, and is in the form of a dry powder that is inhaled. VLPs mimic the live virus since they are basically the shell of protein that surrounds the virus nucleic acid material, but they do not cause infection themselves. Later research will try other means of delivering the vaccine, and it will be tested on other strains of norovirus.
The vaccine was tested at four medical centers on 90 volunteers aged 18-50, 77 of whom completed the per-protocol analysis. The volunteers all had either blood group O or A (since B and AB confer some protection against the virus) and were randomly assigned to one of two groups, one given two doses of the vaccine, and the other given two doses of a placebo. Three weeks after the second dose, they were exposed to the Norwalk norovirus strain and then monitored and tested for antibodies indicating a viral infection.
The results were that 82% of those receiving the placebo became infected with the virus and 69% developed gastroenteritis symptoms, while 61% of those who received the virus became infected, only 37% developed symptoms, and in these people the symptoms were less severe. Dr Atmar said the 18% who had the placebo but did not become infected had probably developed immunity through previous exposure to the virus. Side effects of the dry powder spray (vaccine and placebo) included nasal stuffiness, runny nose and sneezing.
Dr Atmar said norovirus strains cannot be tested using animal models because it does not infect them. It is also impossible to grow in a culture, which makes testing difficult. A protein cultured from the virus was found in the 1990s to self-assemble into the VLPs that have now been used to make the vaccine.
Norovirus is highly infectious and can be easily spread via contaminated water and food. At present the only treatment is to replace fluids to avoid dehydration. The best way of avoiding infection is thorough hand-washing and washing fruit and vegetables.
The paper was published in the New England Journal of Medicine and the research was funded by the vaccine manufacturer, LigoCyte Pharmaceuticals, and by a grant from the National Institutes of Health.
More information: Norovirus Vaccine against Experimental Human Norwalk Virus Illness, N Engl J Med 2011; 365:2178-2187. December 8, 2011. www.nejm.org/doi/f… EJMoa1101245
Journal reference: New England Journal of Medicine
© 2011 Medical Xpress
- New vaccine candidate shows strong potential to prevent highly contagious norovirus Mar 15, 2011 | not rated yet | 0
- NBA players not immune to serious illness from norovirus Oct 31, 2011 | not rated yet | 0
- Protecting your children from the norovirus outbreak in school Nov 12, 2010 | not rated yet | 0
- Study: Flu shot better than nasal spray in adults Sep 23, 2009 | not rated yet | 0
- Combination vaccine protects monkeys from ebola and Marburg viruses Feb 26, 2008 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Why is zone 1 in liver more prone to ischemic injury?
May 23, 2013 Hi, Is it because around central vein, there is only deoxygenated blood from the vein where as in the periphery there is hepatic artery. Also why...
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013 As title suggest. Thanks :smile:
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013 Hello everyone, Ok Stomach's normal epithelium is simple columnar, now in intestinal type of adenocarcinoma of stomach it undergoes "intestinal...
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
- More from Physics Forums - Medical Sciences
More news stories
(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...
Medications 3 hours ago | not rated yet | 0
(AP)—Merck & Co. says it is ending development of an experimental Parkinson's disease drug because the drug wasn't working.
Medications May 23, 2013 | 1 / 5 (1) | 0
(AP)—Johnson & Johnson is developing what could eventually be game-changing treatments for depression and pain, and it's aiming to apply for approval of more than 10 new medicines by 2017, executives said Thursday during ...
Medications May 23, 2013 | 5 / 5 (1) | 0
An independent panel of experts on Wednesday recommended US approval of a new Merck sleeping pill called suvorexant, but expressed concerns over the highest dosage and risks of drowsy daytime driving.
Medications May 22, 2013 | not rated yet | 0
Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...
3 hours ago | not rated yet | 4
Women at a particular stage in their monthly menstrual cycle may be more vulnerable to some of the psychological side-effects associated with stressful experiences, according to a study from UCL.
22 hours ago | 3.7 / 5 (3) | 3 |
Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...
3 hours ago | not rated yet | 1
Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...
19 hours ago | 3 / 5 (2) | 0 |
Biological processes are generally based on events at the molecular and cellular level. To understand what happens in the course of infections, diseases or normal bodily functions, scientists would need to ...
23 hours ago | 5 / 5 (5) | 0 |
Mortality and length of stay are highest in heart failure patients admitted in January, on Friday, and overnight, according to research presented today at the Heart Failure Congress 2013. The analysis of nearly 1 million ...
3 hours ago | not rated yet | 0